On statins: a race-related update

It is relatively common knowledge — although never actually proven in a large, randomized, placebo-controlled trial — that statins like rosuvastatin (Crestor) and atorvastatin (Lipitor) may be helpful in the management of prostate cancer. … READ MORE …

Should every prostate cancer patient be on a statin?

A recent article in the Journal of Clinical Oncology, together with an associated editorial, have addressed the issue of whether evidence is now sufficient to argue that all men with prostate cancer should be treated with a statin. … READ MORE …

More on statins and the management of prostate cancer

A recent data analysis for the Danish national health registry systems has once again provided confirmation of a link between statin use and risk of prostate cancer-specific mortality. … READ MORE …

The safety of treatment with statins (whether you have prostate cancer or not)

In a commentary a couple of days ago we noted some diversity among medical opinion leaders about the safety of treatment with statins. … READ MORE …

Of statins and the prevention and treatment of prostate cancer

The question of whether or not to take a statin to either prevent or actually help in the treatment of prostate cancer has potentially just become moot for many men in America … thanks to new guidance from the US Preventive Services Task Force (USPSTF). … READ MORE …

Statins in the prevention and management of prostate cancer: an update

A recent review article in the journal Nature Reviews: Urology has concluded that, while we are learning a lot more about the potential role(s) of statins in the prevention and management of prostate cancer, we still have no definitive evidence of their value. … READ MORE …

Can statins really lower risk for cancer-specific mortality?

Yet another large, epidemiological study has shown a clear link between taking statins and a reduced risk for cancer-specific death (prostate cancer included). … READ MORE …